carbamates has been researched along with Neuromuscular Junction Diseases in 1 studies
Neuromuscular Junction Diseases: Conditions characterized by impaired transmission of impulses at the NEUROMUSCULAR JUNCTION. This may result from disorders that affect receptor function, pre- or postsynaptic membrane function, or ACETYLCHOLINESTERASE activity. The majority of diseases in this category are associated with autoimmune, toxic, or inherited conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uludag, B | 1 |
| Tarlaci, S | 1 |
| Yuceyar, N | 1 |
| Arac, N | 1 |
1 other study available for carbamates and Neuromuscular Junction Diseases
| Article | Year |
|---|---|
A transient dysfunction of the neuromuscular junction due to carbendazim intoxication.
Topics: Benzimidazoles; Carbamates; Electric Stimulation; Electromyography; Female; Fungicides, Industrial; | 2001 |